We asked whether TFPI1 overexpression is an attempt by the cell to block the tumorigenic potential of increased thrombin levels, or whether the resultant inhibition of the angiogenic pathway leads to a hypoxic state and the subsequent expression of HIF1α, a potent driver of angiogenesis and invasive cancer. The gene discussed is TFPI; the disease is cancer.